Tokyo Tape
Sign in
← Astellas Pharma

Annual report

4503.TEDINET S100YBPK
Period2025-04-01 → 2026-03-31
Filed2026-06-16
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥2.14T2025-04-01 → 2026-03-31Cons.Revenue IFRS
Revenue¥1.91T2024-04-01 → 2025-03-31Cons.Revenue IFRS
Revenue¥1.60T2023-04-01 → 2024-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥1.52T2022-04-01 → 2023-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥1.30T2021-04-01 → 2022-03-31vCons.Revenue IFRS (5-year summary)
Operating income¥382.6bn2025-04-01 → 2026-03-31Cons.Operating profit loss IFRS
Operating income¥41.0bn2024-04-01 → 2025-03-31Cons.Operating profit loss IFRS
Profit before tax¥376.6bn2025-04-01 → 2026-03-31Cons.Profit loss before tax IFRS
Profit before tax¥31.2bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS
Profit before tax¥25.0bn2023-04-01 → 2024-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥132.4bn2022-04-01 → 2023-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥156.9bn2021-04-01 → 2022-03-31vCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥291.5bn2025-04-01 → 2026-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥50.7bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥17.0bn2023-04-01 → 2024-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥98.7bn2022-04-01 → 2023-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥124.1bn2021-04-01 → 2022-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥291.6bn2025-04-01 → 2026-03-31Cons.Profit loss IFRS
Net income¥50.7bn2024-04-01 → 2025-03-31Cons.Profit loss IFRS
Total assets¥3.57Tat 2026-03-31Cons.Assets IFRS
Total assets¥3.34Tat 2025-03-31Cons.Assets IFRS
Total assets¥3.57Tat 2024-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥2.46Tat 2023-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥2.33Tat 2022-03-31vCons.Total assets IFRS (5-year summary)
Total liabilities¥1.74Tat 2026-03-31Cons.Liabilities IFRS
Total liabilities¥1.83Tat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥1.83Tat 2026-03-31Cons.Equity IFRS
Net assets / equity¥1.51Tat 2025-03-31Cons.Equity IFRS
Net assets / equity¥1.60Tat 2024-03-31vCons.Equity IFRS
Equity (owners)¥1.83Tat 2026-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.51Tat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.60Tat 2024-03-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.51Tat 2023-03-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.46Tat 2022-03-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥281.6bnat 2026-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥188.4bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥335.7bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Cash & equivalents¥376.8bnat 2023-03-31vCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥316.0bnat 2022-03-31vCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥560.2bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥194.5bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥172.5bn2023-04-01 → 2024-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥327.8bn2022-04-01 → 2023-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥257.4bn2021-04-01 → 2022-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥66.7bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥89.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥845.8bn2023-04-01 → 2024-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥84.5bn2022-04-01 → 2023-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥62.4bn2021-04-01 → 2022-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥404.8bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥261.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥614.1bn2023-04-01 → 2024-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥195.6bn2022-04-01 → 2023-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥216.3bn2021-04-01 → 2022-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥162.772025-04-01 → 2026-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥28.352024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥9.512023-04-01 → 2024-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥54.242022-04-01 → 2023-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥67.082021-04-01 → 2022-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥162.222025-04-01 → 2026-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥28.242024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥9.472023-04-01 → 2024-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥54.092022-04-01 → 2023-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥67.052021-04-01 → 2022-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,020.96at 2026-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥845.25at 2025-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥890.07at 2024-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥839.26at 2023-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥799.26at 2022-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio51.3%at 2026-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.3%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio44.7%at 2024-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio61.4%at 2023-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.6%at 2022-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE17.4%2025-04-01 → 2026-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE3.3%2024-04-01 → 2025-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE1.1%2023-04-01 → 2024-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE6.7%2022-04-01 → 2023-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE8.7%2021-04-01 → 2022-03-31vCons.Rate of return on equity IFRS (5-year summary)
Employees14,099at 2026-03-31Cons.Number of employees
Employees13,643at 2025-03-31Cons.Number of employees
Employees14,754at 2024-03-31vCons.Number of employees
Employees14,484at 2023-03-31vCons.Number of employees
Employees14,522at 2022-03-31vCons.Number of employees
Revenue¥888.1bn2025-04-01 → 2026-03-31StandaloneNet sales
Revenue¥789.6bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥688.4bn2023-04-01 → 2024-03-31vStandaloneNet sales (5-year summary)
Revenue¥613.6bn2022-04-01 → 2023-03-31vStandaloneNet sales (5-year summary)
Revenue¥542.6bn2021-04-01 → 2022-03-31vStandaloneNet sales (5-year summary)
Operating income¥273.4bn2025-04-01 → 2026-03-31StandaloneOperating income
Operating income¥267.3bn2024-04-01 → 2025-03-31StandaloneOperating income
Ordinary income¥513.1bn2025-04-01 → 2026-03-31StandaloneOrdinary income
Ordinary income¥431.1bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥373.3bn2023-04-01 → 2024-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥338.2bn2022-04-01 → 2023-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥270.5bn2021-04-01 → 2022-03-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax¥434.1bn2025-04-01 → 2026-03-31StandaloneIncome before income taxes
Profit before tax¥362.2bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Net income¥368.0bn2025-04-01 → 2026-03-31StandaloneProfit loss
Net income¥319.7bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥292.2bn2023-04-01 → 2024-03-31vStandaloneNet income loss (5-year summary)
Net income¥314.2bn2022-04-01 → 2023-03-31vStandaloneNet income loss (5-year summary)
Net income¥225.1bn2021-04-01 → 2022-03-31vStandaloneNet income loss (5-year summary)
Total assets¥2.65Tat 2026-03-31StandaloneAssets
Total assets¥2.56Tat 2025-03-31StandaloneAssets
Total assets¥2.46Tat 2024-03-31vStandaloneTotal assets (5-year summary)
Total assets¥1.49Tat 2023-03-31vStandaloneTotal assets (5-year summary)
Total assets¥1.39Tat 2022-03-31vStandaloneTotal assets (5-year summary)
Total liabilities¥1.05Tat 2026-03-31StandaloneLiabilities
Total liabilities¥1.19Tat 2025-03-31StandaloneLiabilities
Net assets / equity¥1.60Tat 2026-03-31StandaloneNet assets
Net assets / equity¥1.37Tat 2025-03-31StandaloneNet assets
Net assets / equity¥1.18Tat 2024-03-31vStandaloneNet assets
Net assets / equity¥1.02Tat 2023-03-31vStandaloneNet assets (5-year summary)
Net assets / equity¥873.6bnat 2022-03-31vStandaloneNet assets (5-year summary)
Cash and deposits¥110.1bnat 2026-03-31StandaloneCash and deposits
Cash and deposits¥46.6bnat 2025-03-31StandaloneCash and deposits
EPS (basic)¥205.472025-04-01 → 2026-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥178.592024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥162.922023-04-01 → 2024-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥172.642022-04-01 → 2023-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥121.692021-04-01 → 2022-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥205.432025-04-01 → 2026-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥178.552024-04-01 → 2025-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥162.872023-04-01 → 2024-03-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥172.572022-04-01 → 2023-03-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥121.632021-04-01 → 2022-03-31vStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥782025-04-01 → 2026-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥742024-04-01 → 2025-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥702023-04-01 → 2024-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥602022-04-01 → 2023-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥502021-04-01 → 2022-03-31vStandaloneDividend paid per share (5-year summary)
Net assets per share¥892.92at 2026-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥763.31at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥660at 2024-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥568.97at 2023-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥477.81at 2022-03-31vStandaloneNet assets per share (5-year summary)
Equity ratio60.4%at 2026-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio53.4%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio48.1%at 2024-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio68.7%at 2023-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio62.9%at 2022-03-31vStandaloneEquity to asset ratio (5-year summary)
ROE24.8%2025-04-01 → 2026-03-31StandaloneRate of return on equity (5-year summary)
ROE25.1%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE26.5%2023-04-01 → 2024-03-31vStandaloneRate of return on equity (5-year summary)
ROE33.2%2022-04-01 → 2023-03-31vStandaloneRate of return on equity (5-year summary)
ROE27.1%2021-04-01 → 2022-03-31vStandaloneRate of return on equity (5-year summary)
Shares issued1,809,663,000at 2026-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,809,663,000at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,809,663,000at 2024-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,809,663,000at 2023-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,835,852,000at 2022-03-31vStandaloneTotal number of issued shares (5-year summary)
Employees4,081at 2026-03-31StandaloneNumber of employees
Employees4,105at 2025-03-31StandaloneNumber of employees
Employees4,806at 2024-03-31vStandaloneNumber of employees
Employees4,867at 2023-03-31vStandaloneNumber of employees
Employees3,943at 2022-03-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceuticalreportable segmentemployeesat 2026-03-3114099 pure
Pharmaceuticalreportable segmentemployeesat 2026-03-314081 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,728
ItemContextValueUnit
Other financial liabilities cl IFRSPrior1YearInstant20144000000JPY
Other financial liabilities cl IFRSCurrentYearInstant22342000000JPY
Other current liabilities cl IFRSPrior1YearInstant187232000000JPY
Other current liabilities cl IFRSCurrentYearInstant235319000000JPY
Total current liabilities IFRSPrior1YearInstant1061610000000JPY
Total current liabilities IFRSCurrentYearInstant1218401000000JPY
Liabilities IFRSPrior1YearInstant1826289000000JPY
Liabilities IFRSCurrentYearInstant1736158000000JPY
Liabilities and equity IFRSPrior1YearInstant3339544000000JPY
Liabilities and equity IFRSCurrentYearInstant3567042000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember103001000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember184070000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-33783000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember809400000000JPY
Equity IFRSPrior2YearInstant_ShareAcquisitionRightsIFRSMember376000000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember518302000000JPY
Profit loss IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YearDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YearDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YearDuration_RetainedEarningsIFRSMember50747000000JPY
Profit loss IFRSPrior1YearDuration_ShareAcquisitionRightsIFRSMember－JPY
Profit loss IFRSPrior1YearDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_ShareAcquisitionRightsIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-9716000000JPY
Comprehensive income IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YearDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YearDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YearDuration_RetainedEarningsIFRSMember50747000000JPY
Comprehensive income IFRSPrior1YearDuration_ShareAcquisitionRightsIFRSMember－JPY
Comprehensive income IFRSPrior1YearDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-9716000000JPY
Purchase of treasury shares ss IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YearDuration_CapitalSurplusIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YearDuration_TreasurySharesIFRSMember-6960000000JPY
Purchase of treasury shares ss IFRSPrior1YearDuration_RetainedEarningsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YearDuration_ShareAcquisitionRightsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YearDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YearDuration_CapitalSurplusIFRSMember-3136000000JPY
Disposal of treasury shares ss IFRSPrior1YearDuration_TreasurySharesIFRSMember3219000000JPY
Disposal of treasury shares ss IFRSPrior1YearDuration_RetainedEarningsIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YearDuration_ShareAcquisitionRightsIFRSMember-78000000JPY
Disposal of treasury shares ss IFRSPrior1YearDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Dividends ss IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Dividends ss IFRSPrior1YearDuration_CapitalSurplusIFRSMember－JPY
Dividends ss IFRSPrior1YearDuration_TreasurySharesIFRSMember－JPY
Dividends ss IFRSPrior1YearDuration_RetainedEarningsIFRSMember-128993000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2026-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass
balance sheet identitynon_consolidated 2026-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net assetsnon_consolidated 2026-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2026-03-31pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenueconsolidated 2024-04-01/2025-03-31pass
statement vs summary · revenueconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2025-04-01/2026-03-31pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2026-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2026-03-31pass